|
1
|
Conlon I and Raff M: Size control in
animal development. Cell. 96:235–244. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu S, Huang J, Dong J and Pan D: Hippo
encodes a Ste-20 family protein kinase that restricts cell
proliferation and promotes apoptosis in conjunction with Salvador
and warts. Cell. 114:445–456. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim
J, Xie J, Ikenoue T, Yu J, Li L, et al: Inactivation of YAP
oncoprotein by the Hippo pathway is involved in cell contact
inhibition and tissue growth control. Genes Dev. 21:2747–2761.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen L, Chan SW, Zhang X, Walsh M, Lim CJ,
Hong W and Song H: Structural basis of YAP recognition by TEAD4 in
the hippo pathway. Genes Dev. 24:290–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang J, Wu S, Barrera J, Matthews K and
Pan D: The Hippo signaling pathway coordinately regulates cell
proliferation and apoptosis by inactivating yorkie, the Drosophila
Homolog of YAP. Cell. 122:421–434. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nolo R, Morrison CM, Tao C, Zhang X and
Halder G: The bantam microRNA is a target of the hippo
tumor-suppressor pathway. Curr Biol. 16:1895–1904. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thompson BJ and Cohen SM: The Hippo
pathway regulates the bantam microRNA to control cell proliferation
and apoptosis in Drosophila. Cell. 126:767–774. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bertini E, Oka T, Sudol M, Strano S and
Blandino G: YAP: At the crossroad between transformation and tumor
suppression. Cell Cycle. 8:49–57. 2009. View Article : Google Scholar
|
|
9
|
Overholtzer M, Zhang J, Smolen GA, Muir B,
Li W, Sgroi DC, Deng CX, Brugge JS and Haber DA: Transforming
properties of YAP, a candidate oncogene on the chromosome 11q22
amplicon. Proc Natl Acad Sci USA. 103:12405–12410. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zender L, Spector MS, Xue W, Flemming P,
Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, et
al: Identification and validation of oncogenes in liver cancer
using an integrative oncogenomic approach. Cell. 125:1253–1267.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sawada A, Kiyonari H, Ukita K, Nishioka N,
Imuta Y and Sasaki H: Redundant roles of Tead1 and Tead2 in
notochord development and the regulation of cell proliferation and
survival. Mol Cell Biol. 28:3177–3189. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang L, Ren F, Zhang Q, Chen Y, Wang B
and Jiang J: The TEAD/TEF family of transcription factor Scalloped
mediates hippo signaling in organ size control. Dev Cell.
14:377–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ota M and Sasaki H: Mammalian Tead
proteins regulate cell proliferation and contact inhibition as
transcriptional mediators of hippo signaling. Development.
135:4059–4069. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu
J, Lin JD, Wang CY, Chinnaiyan AM, et al: TEAD mediates
YAP-dependent gene induction and growth control. Genes Dev.
22:1962–1971. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dupont S, Morsut L, Aragona M, Enzo E,
Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M,
Bicciato S, et al: Role of YAP TAZ in mechanotransduction. Nature.
474:179–183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chan SW, Lim CJ, Loo LS, Chong YF, Huang C
and Hong W: TEADs mediate nuclear retention of TAZ to promote
oncogenic transformation. J Bio Chem. 284:14347–14358. 2009.
View Article : Google Scholar
|
|
17
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global Cancer Statistics. Ca Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Katoh M: Function and cancer genomics of
FAT family genes (review). Int J Oncol. 41:1913–1918.
2012.PubMed/NCBI
|
|
19
|
Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu
Q, Wang Y, Halder G, Finegold MJ, Lee JS, et al: Hippo signaling is
a potent in vivo growth and tumor suppressor pathway in the
mammalian liver. Proc Natl Acad Sci USA. 107:1437–1442. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou Z, Zhu JS, Xu ZP and Zhang Q:
Lentiviral vector-mediated siRNA knockdown of the YAP gene inhibits
growth and induces aoptosis in the SGC7901 gastric cancer cell
line. Mol Med Rep. 4:1075–1082. 2011.PubMed/NCBI
|
|
21
|
Li W, Wang L, Katoh H, Liu R, Zheng P and
Liu Y: Identification of a tumor suppressor relay between the FOXP3
and the Hippo pathways in breast and prostate cancers. Cancer Res.
71:2162–2171. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zagurovskaya M, Shareef MM, Das A, Reeves
A, Gupta S, Sudol M, Bedford MT, Prichard J, Mohiuddin M and Ahmed
MM: EGR-1 forms a complex with YAP-1 and up regulates Bax
expression in irradiated prostate carcinoma cells. Oncogene.
28:1121–1131. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tapon N, Harvey KF, Bell DW, Wahrer DC,
Schiripo TA, Haber D and Hariharan IK: Salvador promotes both cell
cycle exit and apoptosis in Drosophila and is mutated in human
cancer cell lines. Cell. 110:467–478. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishioka N, Inoue K, Adachi K, Kiyonari H,
Ota M, Ralston A, Yabuta N, Hirahara S, Stephenson RO, Ogonuki N,
et al: The Hippo signaling pathway components Lats and Yap pattern
Tead4 activity to distinguish mouse trophectoderm from inner cell
mass. Dev Cell. 16:398–410. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Berney DM: Low Gleason score prostatic
adenocarcinomas are no longer viable entities. Histopathology.
50:683–690. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Na Y, Ye Z and Sun G: Diagnosis and
Treatment Guideline of Chinese Urology Diseases. People's Medical
Publishing House; Beijing: pp. 52–53. 2011, In Chinese.
|
|
27
|
Hudson TS, Perkins SN, Hursting SD, Young
HA, Kim YS, Wang TC and Wang TT: Inhibition of androgen-responsive
LNCaP prostate cancer cell tumor xenograft growth by dietary
phenethyl isothiocyanate correlates with decreased angiogenesis and
inhibition of cell attachment. Int J Oncol. 40:1113–1121.
2012.PubMed/NCBI
|
|
28
|
Sheng X, Li Z, Wang DL, Li WB, Luo Z, Chen
KH, Cao JJ, Yu C and Liu WJ: Isolation and enrichment of PC-3
prostate cancer stem-like cells using MACS and serum-free medium.
Oncol Lett. 5:787–792. 2013.PubMed/NCBI
|
|
29
|
Wang DL, Lan JH, Chen L, Huang B, Li Z,
Zhao XM, Ma Q, Sheng X, Li WB and Tang WX: Integrin-linked kinase
functions as a tumor promoter in bladder transitional cell
carcinoma. Asian Pac J Cancer Prev. 13:2799–2806. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Okamoto Y, Ohkubo T, Ikebe T and Yamazaki
J: Blockade of TRPM8 activity reduces the invasion potential of
oral squamous carcinoma cell lines. Int J Oncol. 40:1431–1440.
2012.PubMed/NCBI
|
|
31
|
De Ganck A, De Corte V, Bruyneel E, Bracke
M, Vandekerckhove J and Gettemans J: Down-regulation of myopodin
expression reduces invasion and motility of PC-3 prostate cancer
cells. Int J Oncol. 34:1403–1409. 2009.PubMed/NCBI
|
|
32
|
Lamar JM, Stern P, Liu H, Schindler JW,
Jiang ZG and Hynes RO: The Hippo pathway target, YAP, promotes
metastasis through its TEAD-interaction domain. Proc Natl Acad Sci
USA. 109:E2441–E2450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong J, Feldmann G, Huang J, Wu S, Zhang
N, Comerford SA, Gayyed MF, Anders RA, Maitra A and Pan D:
Elucidation of a universal size-control mechanism in Drosophila and
mammals. Cell. 130:1120–1133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao B, Li L, Wang L, Wang CY, Yu J and
Guan KL: Cell detachment activates the Hippo pathway via
cytoskeleton reorganization to induce anoikis. Genes Dev. 26:54–68.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yamazaki H, Nishiyama K, Tanaka E, Maeda
O, Meguro N, Kinouchi T, Usami M, Kakimoto K, Ono Y and Nishimura
T: Reduction of irradiation volume and toxicities with 3-D
radiotherapy planning over conventional radiotherapy for prostate
cancer treated with long-term hormonal therapy. Anticancer Res.
28:3913–3920. 2008.
|
|
36
|
Mizuno T, Murakami H, Fujii M, Ishiguro F,
Tanaka I, Kondo Y, Akatsuka S, Toyokuni S, Yokoi K, Osada H, et al:
YAP induces malignant mesothelioma cell proliferation by up
regulating transcription of cell cycle-promoting genes. Oncogene.
31:5117–5122. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cordenonsi M, Zanconato F, Azzolin L,
Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR,
Poletti A, et al: The Hippo transducer TAZ confers cancer stem
cell-related traits on breast cancer cells. Cell. 147:759–772.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rick FG, Schally AV, Szalontay L, Block
NL, Szepeshazi K, Nadji M, Zarandi M, Hohla F, Buchholz S and Seitz
S: Antagonists of growth hormone-releasing hormone inhibit growth
of androgen-independent prostate cancer through inactivation of ERK
and Akt kinases. Proc Natl Acad Sci USA. 109:1655–1660. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang X, Grusche FA and Harvey KF: Control
of tissue growth and cell transformation by the
Salvador/Warts/Hippo pathway. PLoS One. 7:e319942012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT,
Zender L, Lowe SW, Poon RT and Luk JM: Yes-associated protein is an
independent prognostic marker in hepatocellular carcinoma. Cancer.
115:4576–4585. 2009. View Article : Google Scholar : PubMed/NCBI
|
